In addition, when using sevelamer, a ligand that prevents the absorption of Pi, Chertow et al. (2002) found a lower probability of causing hypercalcemia, low PTH levels and progressive coronary aortic calcification in CKD patients. This evidence concerns the gene PTH and chronic kidney disease.